Jean M Elwing Selected Research

Jean M Elwing Research Topics

7	Pulmonary Arterial Hypertension 11/2023 - 03/2017
6	Pulmonary Hypertension 04/2024 - 01/2018
4	Hypertension (High Blood Pressure) 01/2023 - 12/2021
3	Liver Diseases (Liver Disease) 04/2024 - 12/2021
2	Vascular Diseases (Vascular Disease) 12/2021 - 12/2021
2	Familial Primary Pulmonary Hypertension 01/2021 - 10/2019
1	Dyspnea (Shortness of Breath) 11/2023
1	Disease Progression 11/2023
1	Pulmonary Embolism 01/2023
1	Hepatopulmonary Syndrome 12/2021
1	Stroke (Strokes) 01/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 10/2019
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2016
1	Contracture 01/2016
1	Neoplasms (Cancer) 01/2016
1	Systemic Scleroderma (Systemic Sclerosis) 01/2016
1	Synovitis 01/2016
1	Gastric Antral Vascular Ectasia (Watermelon Stomach) 01/2016
1	Fistula 10/2008
1	Tuberous Sclerosis (Bourneville's Disease) 01/2008
1	Stomatitis 01/2008
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2008
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2008
1	Pyelonephritis 01/2008
1	Angiomyolipoma 01/2008
1	Diarrhea 01/2008
1	Respiratory Hypersensitivity 05/2007
1	Asthma (Bronchial Asthma) 05/2007

4	treprostinil FDA Link 11/2023 - 03/2017
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 07/2023 - 01/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2023
1	Nuclear RNAIBA 01/2023
1	Estrogens (Estrogen)FDA Link 01/2023
1	Arginine (L-Arginine)FDA Link 01/2023
1	dimemorfan (AT 17)IBA 07/2022
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 04/2022
1	Endothelin Receptor AntagonistsIBA 04/2022
1	Phosphodiesterase 5 InhibitorsIBA 04/2022
1	riociguatIBA 04/2022
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2021
1	7-(N-(3-aminopropyl)amino)heptan-2-oneIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 02/2020
1	cyclo(Arg-Pro) (CI 4)IBA 01/2020
1	Oral ContraceptivesIBA 10/2019
1	AutoantibodiesIBA 01/2016
1	RNA Polymerase IIIIBA 01/2016
1	Sirolimus (Rapamycin)FDA Link 01/2008
1	TOR Serine-Threonine KinasesIBA 01/2008
1	Interleukin-13IBA 05/2007